Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure

Canadian Journal of Cardiology

Volumn 15, Issue SUPPL. C, 1999, Pages

  Sami, Magdi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

ACE inhibitors; Congestive heart failure; Hypertension; Hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDOLE DERIVATIVE; PERINDOPRIL;

ARTICLE; CONGESTIVE HEART FAILURE; HUMAN; HYPERTENSION; HYPOTENSION; KINESIOTHERAPY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; EXERCISE THERAPY; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; HYPOTENSION; INDOLES; PERINDOPRIL;

EID: 0033129667     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Goldsmith SR, Kubo SH. Pathophysiology of heart failure, peripheral vascular factors and neurohormonal mechanisms. In: Cohn JN, ed. Drug Treatment of Heart Failure, 2nd edn. Secaucus: Advanced Therapeutics Communications International, 1988:49-78.
2. McAlpine HM, Morton JJ, Leckie B, Rumley A, Gillen G, Dargie HJ. Neuroendocrine activation after acute myocardial infarction. Br Heart J 1988;60:117-24.
3. Murray DP, Watson RDS, Zezulka AV, Murray RG, Littler WA. Plasma catecholamine levels in acute myocardial infarction: influence of beta-adrenergic blockade and relation to central hemodynamics. Am Heart J 1988;115:38-44.
4. Rouleau JL, Moyé LA, de Champlain J, et al. Activation of neurohumoral systems following acute myocardial infarction. Am J Cardiol 1991;68:80D-6D.
5. Packer M. Pathophysiology of chronic heart failure. Lancet 1992;340:88-92.
6. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E. Progressive ventricular remodelling in rat with myocardial infarction. Am J Physiol 1991;260:H1406-14.